The Food and Drug Administration (FDA) released this warning yesterday, February 14, regarding the distribution of counterfeit bevacizumab (Avastin) in the United States. The warning includes instructions for what to do if you believe you have bought or received the counterfeit drug.
Avastin’s maker, Genentech, released this statement about the product, including images of both the real and counterfeit products. A Genentech spokesperson said the counterfeit product does not look similar to authentic Avastin that is FDA-approved for the treatment of certain cancers in the United States, including brain tumors.
Reuters reports that Roche and Genentech are “working with the FDA and law enforcement to aid their evaluations, determine the source of the counterfeit drug, and prevent its further distribution.” Other sources reporting on the counterfeit drug are The Associated Press and the Wall Street Journal.
As new information is made available, we will post it on our web site, www.abta.org, as well as here, on the ABTA Facebook page (www.facebook.com/theABTA) and via our Twitter feed (www.twitter.com/theABTA).
Or you can call our CareLine at 800-886-ABTA (2282)and speak with one of our licensed healthcare professionals.